Connect with us
Client Portals
A new article outlines eight key questions employers should consider as cannabis laws continue to evolve across the United States. It emphasizes that while many states now restrict or prohibit pre-employment marijuana testing, employers still retain the ability to…
A new report finds that nearly half of U.S. employers no longer require pre-employment cannabis testing, reflecting changing workplace policies as marijuana legalization expands. The shift is driven by ongoing labor shortages, evolving public attitudes, and growing…
The American Trucking Associations (ATA) is leading a coalition of 19 transportation and safety organizations urging federal agencies to preserve Department of Transportation marijuana testing requirements for safety-sensitive workers if marijuana is reclassified from…
Wyoming has chosen not to adopt the federal government’s reclassification of certain medical cannabis products under state law. Although federal changes moved qualifying medical marijuana to Schedule III, Wyoming Attorney General Keith Kautz determined that the…
Florida employers, particularly those in safety-sensitive industries, are increasingly encouraged to use comprehensive multi-panel drug testing rather than traditional 5-panel screens because today’s substance-use landscape includes fentanyl, synthetic opioids,…
Alaska has enacted a new law allowing people convicted of possessing less than one ounce of marijuana to request that their criminal records be sealed from public view. The measure, which became law without the governor’s signature, is not automatic and requires…
In 2025, nearly 1 in 5 U.S. workers (19.1%) who underwent hair drug testing had positive results, according to the 2026 Quest Diagnostics Drug Testing Index. The report found marijuana positivity in hair tests increased 58.9% over five years, reaching 15.1%, while…
Maine and Oklahoma have enacted new drug testing requirements affecting employer compliance obligations. Oklahoma’s Medical Marijuana Act amendments effective November 1, 2026, provide employers with greater discretion to base adverse actions on marijuana use….
New Jersey employers face new legal exposure following a May 26, 2026 court decision allowing private lawsuits for cannabis-based hiring decisions. While pre-employment drug testing for cannabinoid metabolites remains permissible, employers must carefully evaluate…
The DOJ’s 2026 decision to move certain medical marijuana products to Schedule III has created a “dual framework” under federal law. While the change recognizes accepted medical uses for some cannabis products, recreational marijuana remains federally illegal….